Maple syrup urine disease
MSUD
Maple syrup urine disease (MSUD) is a disorder in which the body cannot break down certain parts of proteins. The urine of people with this condition can smell like maple syrup.
Causes
Maple syrup urine disease (MSUD) is inherited, which means it is passed down through families. It is caused by a defect in 1 of 3 genes. People with this condition cannot break down the amino acids leucine, isoleucine, and valine. This leads to a buildup of these chemicals in the blood.
Amino acids
Amino acids are organic compounds that combine to form proteins. Amino acids and proteins are the building blocks of life. When proteins are digeste...
In the most severe form, MSUD can damage the brain during times of physical stress (such as infection, fever, or not eating for a long time).
Some types of MSUD are mild or come and go. Even in the mildest form, repeated periods of physical stress can cause mental disability and high levels of leucine to build up.
Mental disability
Intellectual disability is a condition diagnosed before age 18 that includes below-average intellectual function and a lack of skills necessary for d...
Symptoms
Symptoms of this disorder include:
- Coma
- Feeding difficulties
-
Lethargy
Lethargy
Fatigue is a feeling of weariness, tiredness, or lack of energy.
-
Seizures
Seizures
A seizure is the physical findings or changes in behavior that occur after an episode of abnormal electrical activity in the brain. The term "seizure...
- Urine that smells like maple syrup
- Vomiting
Exams and Tests
These tests may be done to check for this disorder:
-
Plasma amino acid test
Plasma amino acid test
Plasma amino acids is a screening test done on infants that looks at the amounts of amino acids in the blood. Amino acids are the building blocks fo...
-
Urine organic acid test
Urine organic acid test
Aminoaciduria is an abnormal amount of amino acids in the urine. Amino acids are the building blocks for proteins in the body.
- Genetic testing
There will be signs of ketosis (buildup of ketones, a by-product of burning fat) and excess acid in the blood (acidosis).
Ketosis
A serum ketone test measures how many ketones are there in the blood.
Treatment
When the condition is diagnosed, and during episodes, treatment involves eating a protein-free diet. Fluids, sugars, and sometimes fats are given through a vein (IV). Dialysis through your belly or a vein can be done to reduce the level of abnormal substances in your blood.
Long-term treatment requires a special diet. For infants, the diet includes a formula with low levels of the amino acids leucine, isoleucine, and valine. People with this condition must remain on a diet low in these amino acids for life.
It is very important to always follow this diet to prevent nervous system (neurological) damage. This requires frequent blood tests and close supervision by a registered dietitian and physician, as well as cooperation by parents of children with the condition.
Outlook (Prognosis)
This disease can be life-threatening if untreated.
Even with dietary treatment, stressful situations and illness can still cause high levels of certain amino acids. Death may occur during these episodes. With strict dietary treatment, children have grown into adulthood and can remain healthy.
Possible Complications
These complications can occur:
- Neurological damage
- Coma
- Death
- Mental disability
When to Contact a Medical Professional
Call your health care provider if you have a family history of MSUD and are planning to start a family. Also call your provider right away if you have a newborn who has symptoms of maple syrup urine disease.
Prevention
Genetic counseling is suggested for people who want to have children and who have a family history of maple syrup urine disease. Many states now screen all newborns with blood testing for MSUD.
If a screening test shows that your baby may have MSUD, a follow-up blood test for amino acid levels should be done right away to confirm the disease.
References
Enns GM, Cowan TM, Klein O, Packman S. Aminoacidemias and organic acidemias. In: Swaiman K, Ashwal S, Ferriero DM, Ferriero D, eds. Swaiman's Pediatric Neurology: Principles and Practice . 5th ed. Philadelphia, PA: Elsevier Saunders; 2012:chap 32.
Ogier de Baulny H, Dionisi-Vici C, Wendel U. Branched-chain organic acidurias/acidemias. In: Saudubray J-M, van den Berghe G, Walter JH, eds. Inborn Metabolic Diseases: Diagnosis and Treatment . 5th ed. New York, NY: Springer; 2012:chap 19.
Review Date: 4/20/2015
Reviewed By: Chad Haldeman-Englert, MD, FACMG, Wake Forest School of Medicine, Department of Pediatrics, Section on Medical Genetics, Winston-Salem, NC. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.